Decisions about where and to whose professional stewardship patients are admitted are influenced by federal policies of which physicians might not be aware.
AMA J Ethics. 2023;25(12):E901-908. doi:
10.1001/amajethics.2023.901.
Alysse Gail Wurcel, MD, MS, Jacinda C. Abdul-Mutakabbir, PharmD, MPH, Shira Doron, MD, Christina Yen, MD, and Justin Berk, MD, MPH, MBA
Antimicrobial resistance is a global threat that inequitably affects minoritized populations, including Black, Latinx, and Indigenous people, especially in carceral settings.
AMA J Ethics. 2024;26(5):E399-407. doi:
10.1001/amajethics.2024.399.
Drs Lynne Fehrenbacher and Leah Leonard-Kandarapally join Ethics Talk to discuss key roles of infectious disease pharmacists in antimicrobial stewardship.
Dr Oluwole Jegede joins Ethics Talk to discuss his article, coauthored with Drs Julio C. Nunes, Terence Tumenta, Carmen Black, and Joao P. DeAquino: “What Would Equitable Harm Reduction Look Like?”